Pharmacokinetics of solifenacin in pediatric populations with overactive bladder or neurogenic detrusor overactivity

Abstract The aim of this investigation was to characterize and compare the pharmacokinetics (PK) of the antimuscarinic drug solifenacin in pediatric patients with overactive bladder (OAB) or neurogenic detrusor overactivity (NDO) utilizing data from three phase III trials. LION was a placebo‐control...

ver descrição completa

Detalhes bibliográficos
Main Authors: Stacey Tannenbaum, Martin den Adel, Walter Krauwinkel, John Meijer, Adriana Hollestein‐Havelaar, Frank Verheggen, Donald Newgreen
Formato: Artigo
Idioma:English
Publicado em: Wiley 2020-12-01
Colecção:Pharmacology Research & Perspectives
Assuntos:
Acesso em linha:https://doi.org/10.1002/prp2.684